MS

Sanofi says multiple sclerosis drug Lemtrada shows durable efficacy in extension study
First Word Pharma
Thu, 09/11/14 - 08:08 am
Sanofi
Lemtrada
MS
multiple sclerosis
Novartis wants new treatment goal in MS
Pharmaphorum
Wed, 09/3/14 - 09:03 am
Novartis
MS
multiple sclerosis
Gilenya
Biogen Idec: Drug Approval Offers ‘Underappreciated Earnings Upside,” Morgan Stanley Says
Barron's
Mon, 08/18/14 - 11:52 am
earnings
Biogen Idec
MS
multiple sclerosis
Plegridy
Biogen wins U.S. approval of long acting multiple sclerosis drug
Yahoo/Reuters
Sat, 08/16/14 - 08:35 am
Biogen
MS
Plegridy
Forward Pharma sets sights on Biogen with a $200M IPO
Fierce Biotech
Mon, 08/11/14 - 11:55 am
Forward Pharma
Biogen Idec
IPOs
FP187
MS
multiple sclerosis
Teva eyes 'hard switch' to hit Copaxone goals if the soft sell isn't enough
Fierce Pharma Marketing
Wed, 08/6/14 - 08:14 am
Teva Pharmaceutical
MS
multiple sclerosis
Copaxone
Teva gets more than half of U.S. Copaxone patients converted to long-lasting version
Fierce Pharma
Fri, 08/1/14 - 06:16 pm
Teva Pharmaceutical
MS
multiple sclerosis
Copaxone
Could This 1 Lawsuit Destroy Biogen Idec Stock?
Motley Fool
Tue, 07/22/14 - 05:08 pm
BiogenIdec
Tecfidera
MS
multiple sclerosis
patents
Actavis
Mylan
Synthon Pharmaceuticals
Novartis
Hexal
Sanofi
Zentiva
Alkermes takes its Tecfidera beater into clinical trials for MS
Fierce Biotech
Thu, 07/17/14 - 10:01 am
Alkermes
Tecfidera
MS
multiple sclerosis
FDA's Looming Decision On A Generic To Teva's Copaxone Reveals Drug Approval Woes
Forbes
Mon, 07/7/14 - 07:49 am
Teva Pharmaceutical
Copaxone
generics
MS
multiple sclerosis
FDA
Teva files petition with U.S. FDA against MS drug competitors
Yahoo/Reuters
Thu, 07/3/14 - 10:55 am
Teva Pharmaceutical
FDA
MS
Copaxone
multiple sclerosis
generics
Is this Biogen's Biggest Risk?
Motley Fool
Tue, 07/1/14 - 11:54 pm
Biogen Idec
Tecfidera
MS
multiple sclerosis
Why Teva's Magic Bullet Could Misfire
Motley Fool
Mon, 06/30/14 - 05:57 pm
Teva Pharmaceuticals
Copaxone
MS
multiple sclerosis
Biogen, AbbVie drug slows MS episodes, safety issues recur
Yahoo/Reuters
Mon, 06/16/14 - 08:35 pm
AbbVie
Biogen Idec
MS
multiple sclerosis
daclizumab
Biogen, AbbVie drug slows MS episodes, safety issues recur
Yahoo/Reuters
Mon, 06/16/14 - 10:17 am
Biogen
AbbVie
daclizumab
MS
multiple sclerosis
IPO Stock Watch: Receptos Soars On MS Drug Results
Investors.com
Tue, 06/10/14 - 07:22 pm
IPOs
MS
multiple sclerosis
Receptos
RPC1063
Novartis
Gilenya
Surprising Drug Approval: Time to Buy? (video)
Motley Fool
Sun, 06/1/14 - 11:26 am
multiple sclerosis
MS
PTC Therapeutics
Translarna
[video]Supreme Court + Risky Drug Launch = Billions at Stake
Motley Fool
Fri, 05/30/14 - 12:25 pm
Supreme Court
Teva Pharmaceuticals
Copaxone
generics
MS
multiple sclerosis
Generic Copaxone approval very unlikely this quarter, says Jefferies
The Fly on the Wall
Wed, 05/28/14 - 09:24 am
generics
Copaxone
Teva Pharmaceuticals
MS
multiple sclerosis
Teva, Active Biotech to continue development of Nerventra
The Fly on the Wall
Fri, 05/23/14 - 07:00 am
Teva Pharmaceuticals
Nerventra
Active Biotech
MS
multiple sclerosis

Pages